Robert D. Dick

University of Michigan–Ann Arbor — United States

Nursing · Health Sciences

22h-index3.1kcitations29works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Trace Elements in Health(19), Aluminum toxicity and tolerance in plants and animals(8), Heavy Metal Exposure and Toxicity(7), Cell Adhesion Molecules Research(5), Drug Transport and Resistance Mechanisms(4)

Publications29 total

XIAP Is a Copper Binding Protein Deregulated in Wilson's Disease and Other Copper Toxicosis Disorders
Molecular Cell·2006· 186 citedOpen Access
Effects of Tetrathiomolybdate in a Mouse Model of Retinal Neovascularization
Investigative Ophthalmology & Visual Science·2004· 15 cited
Effects of Tetrathiomolybdate on a Mouse Model of Retinal Neovascularization
2004
A novel role for XIAP in copper homeostasis through regulation of MURR1
The EMBO Journal·2003· 226 citedOpen Access
Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc
Journal of Laboratory and Clinical Medicine·2003· 131 cited
Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model
Archives of Otolaryngology - Head and Neck Surgery·2003· 49 cited
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
PubMed·2002· 440 cited
Radiotherapy and Antiangiogenic TM in Lung Cancer
Neoplasia·2002· 88 citedOpen Access
The Role of Copper Suppression as an Antiangiogenic Strategy in Head and Neck Squamous Cell Carcinoma
The Laryngoscope·2001· 118 cited
Treatment of Wilson's disease with zinc XVI: Treatment during the pediatric years
Journal of Laboratory and Clinical Medicine·2001· 95 cited
Treatment of Wilson’s disease with zinc. XVII: Treatment during pregnancy
Hepatology·2000· 208 citedOpen Access
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
PubMed·2000· 310 cited
Treatment of Wilson's disease with zinc: XV long-term follow-up studies
Journal of Laboratory and Clinical Medicine·1998· 268 cited
Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Brain Research·1996· 234 cited
Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
PubMed·1994· 75 cited
Treatment of Wilson’s Disease with Zinc XII: Dose Regimen Requirements
The American Journal of the Medical Sciences·1993· 45 cited
Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Journal of the American College of Nutrition·1993· 55 cited
Use of zinc acetate to treat copper toxicosis in dogs
Journal of the American Veterinary Medical Association·1992· 63 citedOpen Access
Correction of cerebrospinal fluid copper in Menkes Kinky Hair disease
Pediatric Neurology·1991· 13 citedOpen Access
Initial Therapy of Patients With Wilson's Disease With Tetrathiomolybdate
Archives of Neurology·1991· 189 cited
page 1 of 2Next →

Frequent Co-authors

George J. Brewer(24), Sofía D. Merajver(5), Virginia Johnson(5), G. M. Hill(4), Vilma Yuzbasiyan‐Gurkan(4), Victor M. Elner(4), John K. Fink(3), Karen J. Kluin(3), Ananda S. Prasad(3), Ezra Burstein(2), John Wilkinson(2), Colin S. Duckett(2), Claudell Cox(2), Theodoros N. Teknos(2), Jack E. Juni(2), V Johnson(2), Quintin Pan(1), Celina G. Kleer(1), Luc Van Kaer(1), Jennifer Irani(1)